– What is a pharmaceutical (small molecule vs biologic), innovative, branded, generic product?
– Relative market sizes and evolution over time: market sizes by type, by geographies, by therapeutic area (by sales);
– Top biopharma players; some key products (noticeable breakthroughs rather than simply size);
– Increase in number of companies and products under development (in numbers and by therapeutic area) has been large;
– However, only a small number is approved each year;
– And the cost of developing a drug has increased significantly;
– Industry R&D productivity has been in serious decline for years;
– But opportunities for successful products still exist…
– What does it take to develop a product?
– Tunnel charts: show how long it takes to develop a drug (pre-competitive and competitive spaces);
– Approval rates and costs by phase (and by therapeutic area?);
– Product lifecycle;
– Characterization of industry segments;
– Forces of change: overview of strategic.
